Skip to content

Taxes Paid at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.63B-2.6%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
$1.64M
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$923.5K+141%

Other financials

Income statement

See full
Revenue-
Operating income-$53.7M+2.4%
Net income-$49.7M-2.4%
EPS (diluted)-$0.69+24.2%

Balance sheet

See full
Cash & equivalents$75.1M-2.1%
Total debt$2.4M+29.5%
Total equity$408.7M-30.8%
Total assets$403.0M-30.5%

Cash flow

See full
Operating cash flow-$46.0M-6.7%
CapEx$11.0K
Free cash flow-$38.1M-4.1%

Valuation

See full
Market cap$1.08B+94.2%
Enterprise value$1.01B+114%

Profitability

See full
Operating margin-358.7%
Net margin-346.1%

Returns & leverage

See full
Return on equity-44%+26.2pp
Debt / equity0.0×
Current ratio10.3×-1.3×

Where this comes from

Reported directly by Cullinan Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed August 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Cullinan Therapeutics, Inc.'s taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cullinan Therapeutics, Inc.'s taxes paid?
Cullinan Therapeutics, Inc. (CGEM) reported taxes paid of -$2.97M in Q2 2025.
What does taxes paid mean?
Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.